| mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.9 |
| mRNA |
QL-XII-61 |
GDSC1000 |
pan-cancer |
AAC |
0.0094 |
0.9 |
| mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
| mRNA |
XMD11-85h |
GDSC1000 |
pan-cancer |
AAC |
-0.0091 |
0.9 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.9 |
| mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.9 |
| mRNA |
KIN001-236 |
GDSC1000 |
pan-cancer |
AAC |
-0.006 |
0.9 |
| mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
0.0055 |
0.9 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
| mRNA |
Pazopanib |
FIMM |
pan-cancer |
AAC |
0.027 |
0.9 |